Form D · Biotechnology

CareDx, Inc.

Brisbane, CA · CIK 0001217234

Offering snapshot reported Jun 17, 2016 · SEC filing

Reported sold
$22.2M
Offering amount: $36.8M
Investors reported
42
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 14, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.1M$22.2MApr 28, 2016: $14,169,129.00Apr 28, 2016Jun 17, 2016: $22,169,135.00Jun 17, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$14,169,129 → $22,169,135
  • Reported investors39 → 42

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 17, 2016Amendment$22,169,135$8,000,006vs Apr 28, 201642SEC filing
Apr 28, 2016Initial$14,169,129No comparison39SEC filing
Nov 15, 2011Initial$2,155,781No comparison31SEC filing
Jul 12, 2010Initial$6,041,511No comparison48SEC filing
Jun 3, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 14, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.08M
Finders' fees
$11.7K
Form D file number
021-262245
The Total Offering Amount and Total Remaining to be Sold include up to $14,632,873.26 to be received upon exercise of warrants.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leerink Partners LLC39011
CIM Securities, LLC120852
M.M. Dillon & Co. Group19878

Source: Form D, filed Jun 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Altman Director
George Bickerstaff Director
G. Steven Burrill Director
Brook Byers Director
Pierre Cassigneul Director, Executive
Fred Cohen Director
Charles Constanti Executive
Michael Goldberg Director
William Hagstrom Director
Anders Karlsson Executive
Vijay Lathi Director
David Levison Director
Peter Maag Director, Executive
Matthew Myer Executive
Mitchell Nelles Executive
John Sninsky Executive
Ralph Snyderman Director
Jean Viret Executive
Todd Whitson Executive
James Yee Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3260 Bayshore Boulevard
Brisbane, CA, 94005